devdiscourse25m
Global Health Developments: From Pharma Deals to Drug Policy Updates
In the rapidly evolving health sector, Blackstone and Bain Capital are vying to acquire Mitsubishi Tanabe Pharma, potentially valuing the Japanese subsidiary at up to $3.5 billion. Sources reveal that ...
Fed to Cut Once More Before Slowing Pace in 2025, Economists Say
Federal Reserve officials will lower interest rates this month for a third straight time and pare back the number of rate ...
Business Standard2h
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 bn deal
Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan ...
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 billion deal, sources say
Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan ...
The Globe and Mail13h
Blackstone and Bain Capital among final bidders for Mitsubishi pharma unit, sources say
Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan ...